Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis June 14, 2019 - NASDAQ Companies 0 » View More News for June 14, 2019